Similar articles for PMID: 16176554

Year	Number of Results
1966	1
1969	1
1985	1
1987	1
1995	1
1997	1
1998	4
1999	2
2000	2
2001	5
2002	9
2003	6
2004	10
2005	24
2006	14
2007	13
2008	12
2009	17
2010	18
2011	12
2012	14
2013	13
2014	7
2015	8
2016	9
2017	9
2018	8
2019	7
2021	4
2022	7
2024	0

1

Molecular pharmacology and therapeutic prospects of metabotropic glutamate receptor allosteric modulators.

Ritzén A, Mathiesen JM, Thomsen C. Ritzén A, et al. Basic Clin Pharmacol Toxicol. 2005 Oct;97(4):202-13. doi: 10.1111/j.1742-7843.2005.pto_156.x. Basic Clin Pharmacol Toxicol. 2005. PMID: 16176554 Free article. Review.

2

Metabotropic glutamate receptors: synaptic modulators and therapeutic targets for neurologic disease.

Benarroch EE. Benarroch EE. Neurology. 2008 Mar 18;70(12):964-8. doi: 10.1212/01.wnl.0000306315.03021.2a. Neurology. 2008. PMID: 18347319 Review. No abstract available.

3

[Metabotropic glutamate receptors: new molecular targets in the treatment of neurological and psychiatric diseases].

Luján-Miras R. Luján-Miras R. Rev Neurol. 2005 Jan 1-15;40(1):43-53. Rev Neurol. 2005. PMID: 15696426 Free article. Review. Spanish.

4

[Metabotropic glutamate receptors as targets for new drug development].

Arkhipov VI, Kapralova MV. Arkhipov VI, et al. Eksp Klin Farmakol. 2011;74(10):46-52. Eksp Klin Farmakol. 2011. PMID: 22238988 Review. Russian.

5

Positive and negative allosteric modulation of metabotropic glutamate receptors: emerging therapeutic potential.

Kew JN. Kew JN. Pharmacol Ther. 2004 Dec;104(3):233-44. doi: 10.1016/j.pharmthera.2004.08.010. Pharmacol Ther. 2004. PMID: 15556676 Review.

6

Metabotropic glutamate mGlu1 receptor stimulation and blockade: therapeutic opportunities in psychiatric illness.

Lesage A, Steckler T. Lesage A, et al. Eur J Pharmacol. 2010 Aug 10;639(1-3):2-16. doi: 10.1016/j.ejphar.2009.12.043. Epub 2010 Apr 2. Eur J Pharmacol. 2010. PMID: 20371230 Review.

7

Metabotropic glutamate receptors as a strategic target for the treatment of epilepsy.

Alexander GM, Godwin DW. Alexander GM, et al. Epilepsy Res. 2006 Sep;71(1):1-22. doi: 10.1016/j.eplepsyres.2006.05.012. Epub 2006 Jun 19. Epilepsy Res. 2006. PMID: 16787741 Review.

8

Glutamate as a therapeutic target in psychiatric disorders.

Javitt DC. Javitt DC. Mol Psychiatry. 2004 Nov;9(11):984-97, 979. doi: 10.1038/sj.mp.4001551. Mol Psychiatry. 2004. PMID: 15278097 Review.

9

A family of highly selective allosteric modulators of the metabotropic glutamate receptor subtype 5.

O'Brien JA, Lemaire W, Chen TB, Chang RS, Jacobson MA, Ha SN, Lindsley CW, Schaffhauser HJ, Sur C, Pettibone DJ, Conn PJ, Williams DL Jr. O'Brien JA, et al. Mol Pharmacol. 2003 Sep;64(3):731-40. doi: 10.1124/mol.64.3.731. Mol Pharmacol. 2003. PMID: 12920211

10

Transposition of three amino acids transforms the human metabotropic glutamate receptor (mGluR)-3-positive allosteric modulation site to mGluR2, and additional characterization of the mGluR2-positive allosteric modulation site.

Rowe BA, Schaffhauser H, Morales S, Lubbers LS, Bonnefous C, Kamenecka TM, McQuiston J, Daggett LP. Rowe BA, et al. J Pharmacol Exp Ther. 2008 Jul;326(1):240-51. doi: 10.1124/jpet.108.138271. Epub 2008 Apr 22. J Pharmacol Exp Ther. 2008. PMID: 18430863

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

208 results

Results by year